about
sameAs
Cetuximab, Docetaxel, Cisplatin, and Radiation Therapy in Treating Patients With Locally Advanced Esophageal Cancer That Can Be Removed by SurgeryPilot Study of Allogeneic Tumor Cell Vaccine With Metronomic Oral Cyclophosphamide and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers, Thymic Neoplasms, and Malignant Pleural MesotheliomasTumor Cell Vaccines With ISCOMATRIX Adjuvant and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers and Malignant Pleural MesotheliomasTo Evaluate the Efficacy of NY-ESO-1-specific T Cell Receptor (TCR) Affinity Enhancing Specific T Cell in Solid TumorsPerioperative Chemo and Pembrolizumab in Gastric CancerA Multicenter Open-label Phase II Trial to Evaluate Nivolumab and Ipilimumab for 2nd Line Therapy in Elderly Patients With Advanced Esophageal Squamous Cell CancerT Cell Receptor-transduced T Cells Targeting NY-ESO-1 for Treatment of Patients With NY-ESO-1- Expressing MalignanciesEpacadostat and Pembrolizumab Before Surgery in Treating Participants With Stage II-III Esophageal or Gastroesophageal CancerAvelumab With Chemoradiation for Stage II/III Resectable Esophageal CancerThe Effects of Upper Airway and Digestive Tract Tumors on the Immune SystemSafety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer.CD8+ T Cell Therapy and Pembrolizumab in Treating Patients With Metastatic Gastrointestinal TumorsCombination of Cryosurgery and NK Immunotherapy for Advanced Esophageal CancerMultiorgan Metabolic Imaging Response Assessment of AbemaciclibStudy Title: Peri-operative Immuno-Chemotherapy in Operable Oesophageal and Gastric CancerIpilimumab or FOLFOX in Combination With Nivolumab and Trastuzumab in HER2 Positive EsophagoGastric AdenocarcinomaNivolumab and Ipilimumab in Treating Patients With Esophageal and Gastroesophageal Junction Adenocarcinoma Undergoing SurgeryAutologous CAR-T/TCR-T Cell Immunotherapy for MalignanciesA Study to Evaluate the Safety and Effectiveness of ILIxadencel Administered Into Tumors in Combination With Checkpoint Inhibitor (CPI) in Patients With ADvanced CancerMM-398 and Ramucirumab in Treating Patients With Gastric Cancer or Gastroesophageal Junction AdenocarcinomaChemotherapy, Radiation Therapy and Immunotherapy Prior to Surgery in Operable Esophageal Cancer
P1050
P527
The alcohol flushing response: an unrecognized risk factor for esophageal cancer from alcohol consumptionNeoadjuvant or adjuvant therapy for resectable esophageal cancer: a systematic review and meta-analysisCirculating Tumor Cells in the Adenocarcinoma of the EsophagusThe detective, prognostic, and predictive value of DNA methylation in human esophageal squamous cell carcinomaEmerging therapeutic targets in esophageal adenocarcinomaPrognostic Value of Perineural Invasion in Esophageal and Esophagogastric Junction Carcinoma: A Meta-AnalysisAn update of the WCRF/AICR systematic literature review on esophageal and gastric cancers and citrus fruits intakeTraditional serrated adenomas of the upper digestive tractPredictive Value of Ercc1 and Xpd Polymorphisms for Clinical Outcomes of Patients Receiving Neoadjuvant Therapy: A Prisma-Compliant Meta-AnalysisTeeth loss, teeth brushing and esophageal carcinoma: a systematic review and meta-analysisGenetic Biomarkers of Barrett's Esophagus Susceptibility and Progression to Dysplasia and Cancer: A Systematic Review and Meta-AnalysisOptimal first-line chemotherapeutic treatment in patients with locally advanced or metastatic esophagogastric carcinoma: triplet versus doublet chemotherapy: a systematic literature review and meta-analysisPrimary Esophageal Extranasal NK/T Cell Lymphoma With Biphasic Morphology: A Case Report and Literature ReviewMeta-Analysis of Prognostic and Clinical Significance of CD44v6 in Esophageal CancerEstimates of alcohol-related oesophageal cancer burden in Japan: systematic review and meta-analysesAdvances in targeted therapies and new promising targets in esophageal cancerBenign, premalignant, and malignant lesions encountered in bariatric surgeryThe potential of molecular markers to improve interventions through the natural history of oesophageal squamous cell carcinomaClinical management of gastroesophageal junction tumors: past and recent evidences for the role of radiotherapy in the multidisciplinary approachThe value of [18F]fluorodeoxyglucose-PET/CT in oesophageal cancerAlterations of the TP53 gene in gastric and esophageal carcinogenesisRetrograde stapling of a free cervical jejunal interposition graft: a technical innovation and case reportThe -1082A>G polymorphism in promoter region of interleukin-10 and risk of digestive cancer: a meta-analysisSignaling pathways in the molecular pathogenesis of adenocarcinomas of the esophagus and gastroesophageal junctionBisphosphonates and evidence for association with esophageal and gastric cancer: a systematic review and meta-analysis.Human papillomavirus and gastrointestinal cancer: A reviewThe role of cancer-associated fibroblasts in esophageal cancerInvolved-field radiotherapy for esophageal squamous cell carcinoma: theory and practicePositioning of second-line treatment for advanced gastric and gastroesophageal junction adenocarcinomaComparison of two different mechanical esophagogastric anastomosis in esophageal cancer patients: a meta-analysisSystematic review and meta-analysis of immunohistochemical prognostic biomarkers in resected oesophageal adenocarcinomaALDH2 polymorphism and alcohol-related cancers in Asians: a public health perspectiveHuman papillomavirus-related esophageal cancer survival: A systematic review and meta-analysisSecond- and third-line systemic therapy in patients with advanced esophagogastric cancer: a systematic review of the literature.Developing core outcomes sets: methods for identifying and including patient-reported outcomes (PROs).Prevalence of human papillomavirus among oesophageal squamous cell carcinoma cases: systematic review and meta-analysisAbdominal obesity and gastroesophageal cancer risk: systematic review and meta-analysis of prospective studiesRenal metastasis after esophagectomy of esophageal squamous cell carcinoma: a case report and literature review.Probing the link between oestrogen receptors and oesophageal cancer.Trends in esophageal and esophagogastric junction cancer research from 2007 to 2016: A bibliometric analysis.
P921
Q58407437-C21A46E3-F91C-40DA-9E24-3A49EE0768CEQ58407540-B540AD1B-DA6A-4962-A91A-2A7005BC9A76Q58407557-8107F57F-84B9-4CE2-9185-C604CD735B9DQ58407667-54475578-16CE-4BF8-8790-E662903AF340Q58407675-588946DF-EDB3-4E7A-9EB9-751F4D0CF5C0Q58407691-22FD3AFD-37A3-4BAD-9F11-B252B08A5597Q58407716-0CDC8586-2B82-48F6-912F-6772F30D7E2AQ58407744-01437744-3C79-4251-9DBA-01B903845AEAQ58407817-0B463A13-E515-4FC3-8DB4-475DFBA467A4Q58843885-74B04C5F-FCF3-4B68-8ACC-088C2D9FE394Q58844415-D90E5FAA-E472-4AC6-9F8A-A7332B936D85Q58845549-2EAD0ADF-9F88-46F6-93EA-F571DFAB1BA2Q58845655-609B3F56-FE15-400E-9A51-55ADFF244B3EQ58846611-4EBB36A3-1471-4320-A713-AE19B2605506Q58846763-713238A6-10B6-422B-9053-1E6660FBFC9FQ58846782-3DB7493D-4801-407F-83BC-753157CD0F3BQ58847052-E39F5A21-4678-49BE-9226-2539B0363EDAQ58847097-E69FFBF9-3146-4139-9D1F-E196BA509EF0Q58847236-D922D888-1E60-4E89-A465-01F20A1CBA3BQ58847256-8EB75712-27F0-49F0-B215-7194CAC23FB1Q58849095-0DEA44E8-53BF-4EBC-B9D4-86EED437EC56
P1050
Q21144641-C3AB5E49-60B9-4A31-8D25-CD3ABB36947CQ24797571-C657A290-1FA3-4032-A6A0-0EBD774B3CC6Q26741429-715DF456-CB30-4486-94AF-CAD1C762EE11Q26750641-F2BDE66C-13AF-4C3B-B63F-E81FABAE6DAEQ26751209-6F3ED9E1-1904-4A50-9677-AF8D0966E5C5Q26751370-B71F5E3A-9C69-48A7-828D-1F22DFAF3E7DQ26751453-39BAB8DC-A768-4326-AC9E-3DB83680B9E3Q26782819-2A35EA5A-52E3-489B-A3C9-836A12E21130Q26782962-E665FFC6-5BC3-4576-A501-7A5DC9E98D2BQ26783665-FA28DB2F-DDDA-487B-9E8A-896B98AD0AE1Q26786469-AAD267A6-42FC-4C1C-A7E3-F6937223241CQ26798400-8AF16FEA-16AD-4BAE-8E2C-AFF165456921Q26800228-3BE943C3-BFDB-4E92-9B82-F2B104807C96Q26801136-3158C841-0EB0-49B3-BF80-527DD774B003Q26801263-930F3014-23E1-4CF5-BBBA-FC64526034FEQ26825957-08AA02DC-8BE3-4FC9-994D-A3127B91BF28Q26827258-A26026F3-A9C6-40D4-9A71-FC39A462C8A1Q26829483-8B80F2E8-9E5E-4267-91D8-1E28A3945393Q26862365-3F6C0C83-6B64-4320-B618-0DC480E3352BQ26864611-C3688F06-7CE2-4AB9-86DE-0ED99BCE6B4BQ26866191-9EAE1419-28A3-40A9-B373-64CDD67E121AQ26999883-FF3CC680-4B43-4617-98F8-85A85489462DQ27002441-1E608ED7-3297-4AC8-B5E8-33DDE3A0DE3FQ27026253-99978D3E-790B-4F49-9CE2-AD8B4C0C699CQ27693291-F69E7536-1B01-4A7B-932C-5A5110C830D7Q28069930-D8DC055C-F6E8-4747-9E49-377DF659433FQ28073714-ECA1D456-5A36-4087-9B69-DAAACC766F96Q28073933-72925F39-46A6-4D5B-B590-E1531FD01E00Q28079750-C769B574-4D29-46C0-B5FB-630C0AE4646BQ28084114-501A9EC1-319B-4625-9DA4-DDC240DAD39AQ28085367-8E0EC50A-8476-45D8-90BB-203C5CA4E909Q30235490-82FE5BD8-2778-4786-AC4C-06BBFD69D2A6Q30241058-BB3AD59B-B6D4-4309-B40F-E14B59423434Q30249003-E7296FBB-2A93-4A85-92EE-463650D16846Q30571178-BB5AE286-8723-47C3-8DE4-C6328C10BB06Q33555309-7BDEACDA-0D86-45F9-A1DB-0DC6CE8183CCQ33661718-D3B0D79B-8D1E-46E4-86A0-B38719780405Q33680798-888F745D-AE2C-4B07-B464-BD3540476EB3Q33702570-9A9D2308-9F20-4521-B3E5-67D23561B9FFQ33714435-225955E8-41D3-40E3-AC8E-C32A54CC24AF
P921
description
neoplasm (disease) that involves the esophagus
@en
name
esophageal neoplasm
@en
tumeur de l'oesophage
@fr
type
label
esophageal neoplasm
@en
tumeur de l'oesophage
@fr
altLabel
Esophageal Neoplasm
@en
Esophageal Neoplasms, Benign and Malignant
@en
Esophageal Tumor
@en
Esophageal Tumors
@en
Esophagus Neoplasm
@en
Neoplasm of the Esophagus
@en
Tumor of Esophagus
@en
Tumor of the Esophagus
@en
esophageal neoplasms
@en
esophagus neoplasm (disease)
@en
prefLabel
esophageal neoplasm
@en
tumeur de l'oesophage
@fr
P279
P672
P486
P1748
P2892
P31
P486
P5270
MONDO:0021355
P672
C04.588.274.476.205
C04.588.443.353
C06.301.371.205
C06.405.117.430
C06.405.249.205